| Ms Lori Ann Tabbert, RPH | |
|
113 N 9th St, Adel, IA 50003-1443 | |
| (515) 993-3644 | |
| Not Available |
| Full Name | Ms Lori Ann Tabbert |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 113 N 9th St, Adel, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790773711 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 17881 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lori Ann Tabbert, RPH 2370 330th St, Adel, IA 50003-8114 Ph: (515) 834-2163 | Ms Lori Ann Tabbert, RPH 113 N 9th St, Adel, IA 50003-1443 Ph: (515) 993-3644 |
News Archive
In a first for medical science, University of North Carolina at Chapel Hill pharmacy researchers turn skin cells into cancer-hunting stem cells that destroy brain tumors known as glioblastoma - a discovery that can offer, for the first time in more than 30 years, a new and more effective treatment for the disease.
Illumina, Inc. today announced a new price of $19,500 for its individual genome sequencing service. In addition, the company announced a price of $14,500 per genome for groups of five or more participants using the same physician. Individuals with serious medical conditions for whom whole-genome sequencing could provide potential direct clinical value will be eligible for special pricing of $9,500 per genome.
Scottsdale Healthcare is the only Arizona hospital system testing a new under-the-skin device that uses an electrical shock to interrupt possibly fatal heart rhythms, restoring a normal heartbeat for patients at high risk of sudden cardiac arrest.The first Arizona patient received the device Thursday at Scottsdale Healthcare Shea Medical Center. Scottsdale Healthcare is the only Phoenix area hospital and one of only 35 in the world participating in the study.
High altitude medicine is a "natural research laboratory" for the study of cardiovascular physiology and pathophysiology. As such, it can shed light on conditions and diseases that mimic the low oxygen content of the atmosphere at the top of mountains. Yves Allemann, MD, FESC, Swiss Cardiovascular Center, University Hospital, Bern, and Urs Scherrer, MD, Centre Hospitalier Universitaire Vaudois, Lausanne, have assembled an international group of leading authorities to contribute to a special issue of Progress in Cardiovascular Diseases.
AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioXpress Therapeutics SA, a Swiss-based biotechnology company developing monoclonal antibody (MAb) biosimilars have entered into an agreement for the co-development of a biosimilar version of the TNF inhibitor MAb Adalimumab.
› Verified 4 days ago
Jane Clausen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 113 N 9th St, Adel, IA 50003 Phone: 515-993-3644 Fax: 515-993-4714 | |
Leslie Herron, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 628 Nile Kinnick Dr S Ste 1, Adel, IA 50003 Phone: 515-993-1119 Fax: 515-993-1116 | |
Theresa Tripp, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1312 Grove St, Adel, IA 50003 Phone: 515-778-9568 |